17.83
price down icon0.89%   -0.16
after-market After Hours: 17.85 0.02 +0.11%
loading

Myriad Genetics Inc Stock (MYGN) Forecast

The Myriad Genetics Inc (MYGN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $16.86, representing a -5.47% decrease from the current price of $17.83. The highest analyst price target is $18.44, and the lowest is $15.27.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MYGN Price Target
Average 11.54 (-35.29% Downside)
loading

Is Myriad Genetics Inc (MYGN) A Buy Now?

Oscillators
Name Value Action
RSI(14) 21.93 Buy
STOCH(9,6) 26.01 Neutral
STOCHRSI(14) 48.80 Neutral
MACD(12,26) -1.6584 Sell
ADX(14) 37.05 Sell
William %R -87.19 Buy
CCI(14) -245.57 Sell
Buy: 2 Sell: 3 Neutral: 2
Summary: Sell
Moving Averages
Period Simple Exponential
MA10
21.31
Sell
21.01
Sell
MA20
22.64
Sell
22.41
Sell
MA50
25.36
Sell
24.32
Sell
MA100
25.83
Sell
24.72
Sell
MA200
23.82
Sell
23.63
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, MYGN could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on MYGN, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 21.93 indicates that MYGN is oversold. This indicates that MYGN price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 26.01 indicates that MYGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 48.8 indicates that MYGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 37.05 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -245.57 indicates that MYGN is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term MYGN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Myriad Genetics Inc financial reports and earnings history, Myriad Genetics Inc (MYGN) stock could reach $10.55 by 2030, $4.3564 by 2040 and $10.70 by 2050. See the projected annual prices until 2050 of the Myriad Genetics Inc stock below:

  • Myriad Genetics Inc (MYGN) is expected to reach an average price of $5.6409 in 2035, with a high prediction of $6.9404 and a low estimate of $1.3699. This indicates an $-68.36% rise from the last recorded price of $17.83.
  • Myriad Genetics Inc (MYGN) stock is projected to chart a bullish course in 2040, with an average price target of $1.8163, representing an $-89.81% surge from its current level. The forecast ranges from a conservative $1.0936 to a sky-high $4.3564.
  • Our analysts predict Myriad Genetics Inc (MYGN) to jump -57.84% by 2045, soaring from $6.6428 to an average price of $7.5163, potentially reaching $7.0718. While $6.6428 is the low estimate, the potential upside is significant.
  • Myriad Genetics Inc (MYGN) stock is expected to climb by 2050, reaching an average of $9.3546, a $-47.53% jump from its current level. However, a wide range of estimates exists, with high and low targets of $10.70 and $11.44, respectively, highlighting the market's uncertainty.

Myriad Genetics Inc Stock (MYGN) Year by Year Forecast

Myriad Genetics Inc Stock (MYGN) Price Forecast for 2024

Our forecast for MYGN stock price in 2024 now indicates an average price target of $25.69 with a high forecast of $39.57 and a low forecast of $11.81. The average prediction reflects an increase of +44.07% from the last recorded price of $17.83.
Month Average Low High Change from today's price
December, 2024 $17.39 $15.27 $18.44 -2.45%

Myriad Genetics Inc Stock (MYGN) Price Forecast for 2025

Myriad Genetics Inc Stock (MYGN) is expected to reach an average price of $11.54 in 2025, with a high prediction of $21.95 and a low estimate of $1.1248. This indicates an -35.29% fall from the last recorded price of $17.83.
Month Average Low High Change from today's price
January, 2025 $18.66 $16.21 $20.47 +4.67%
February, 2025 $19.44 $18.24 $21.71 +9.02%
March, 2025 $8.8882 $8.5182 $21.95 -50.15%
April, 2025 $5.9726 $1.1248 $10.54 -66.50%
May, 2025 $7.0681 $3.9614 $8.1703 -60.36%
June, 2025 $6.7036 $5.2447 $8.1036 -62.40%
July, 2025 $4.1879 $3.5741 $8.9193 -76.51%
August, 2025 $3.5234 $2.5669 $4.7768 -80.24%
September, 2025 $4.2789 $3.1648 $4.7389 -76.00%
October, 2025 $4.5233 $3.9433 $7.1567 -74.63%
November, 2025 $5.2088 $3.9199 $6.121 -70.79%
December, 2025 $4.7032 $3.9754 $7.1132 -73.62%

Myriad Genetics Inc Stock (MYGN) Price Forecast for 2026

The predicted value for Myriad Genetics Inc (MYGN) in 2026 is set at an average of $17.18. Estimates vary from a peak of $29.58 to a trough of $4.772, indicating an -3.65% surge from the present price of $17.83.
Month Average Low High Change from today's price
January, 2026 $10.03 $4.772 $11.07 -43.75%
February, 2026 $10.29 $9.4375 $12.42 -42.26%
March, 2026 $19.03 $9.693 $19.66 +6.73%
April, 2026 $23.70 $17.24 $23.95 +32.94%
May, 2026 $22.89 $19.14 $24.94 +28.38%
June, 2026 $20.60 $19.39 $26.41 +15.51%
July, 2026 $19.86 $17.02 $24.47 +11.38%
August, 2026 $22.24 $18.57 $22.59 +24.76%
September, 2026 $25.69 $21.04 $25.73 +44.08%
October, 2026 $27.04 $22.27 $28.66 +51.68%
November, 2026 $28.41 $24.86 $29.58 +59.34%
December, 2026 $24.98 $23.48 $29.55 +40.13%

Myriad Genetics Inc Stock (MYGN) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Myriad Genetics Inc (MYGN) is $17.43, with a high forecast of $25.79 and a low forecast of $9.0762. This indicates an -2.22% decrease from the last price of $17.83.
Month Average Low High Change from today's price
January, 2027 $25.21 $23.21 $25.79 +41.39%
February, 2027 $20.81 $20.37 $25.40 +16.69%
March, 2027 $17.66 $16.34 $21.27 -0.95%
April, 2027 $20.62 $16.98 $21.27 +15.62%
May, 2027 $18.01 $16.48 $20.89 +1.01%
June, 2027 $15.58 $15.35 $20.36 -12.65%
July, 2027 $18.14 $15.26 $20.67 +1.74%
August, 2027 $14.95 $14.56 $19.40 -16.17%
September, 2027 $16.14 $11.98 $16.35 -9.47%
October, 2027 $9.6062 $9.0762 $15.82 -46.12%
November, 2027 $12.75 $9.7451 $12.94 -28.48%
December, 2027 $20.75 $12.06 $21.32 +16.35%

Myriad Genetics Inc Stock (MYGN) Price Forecast for 2028

In 2028, Myriad Genetics Inc (MYGN) is projected to reach an average price of $14.16, with a high projection of $21.06 and a low estimate of $7.2602. This indicates an -20.57% fall from the last price of $17.83.
Month Average Low High Change from today's price
January, 2028 $14.99 $14.79 $21.06 -15.92%
February, 2028 $12.29 $11.23 $16.71 -31.09%
March, 2028 $13.99 $11.37 $14.31 -21.53%
April, 2028 $12.93 $8.6403 $15.44 -27.50%
May, 2028 $8.9713 $8.8013 $14.30 -49.68%
June, 2028 $13.72 $7.2602 $13.76 -23.07%
July, 2028 $12.05 $11.57 $15.09 -32.40%
August, 2028 $14.68 $11.26 $17.33 -17.69%
September, 2028 $16.81 $14.22 $17.51 -5.71%
October, 2028 $12.81 $11.83 $17.23 -28.17%
November, 2028 $16.99 $10.87 $17.14 -4.70%
December, 2028 $16.78 $15.13 $17.81 -5.90%

Myriad Genetics Inc Stock (MYGN) Price Forecast for 2029

The 2029 price forecast for Myriad Genetics Inc Stock (MYGN) is $12.83 on average, with a high prediction of $18.07 and a low estimate of $7.5861. This represents an -28.05% decrease from the previous price of $17.83.
Month Average Low High Change from today's price
January, 2029 $15.99 $15.20 $17.11 -10.31%
February, 2029 $11.38 $10.08 $16.12 -36.19%
March, 2029 $10.32 $8.844 $12.03 -42.10%
April, 2029 $8.2884 $8.2184 $11.32 -53.51%
May, 2029 $10.24 $7.5861 $13.15 -42.55%
June, 2029 $13.06 $9.9016 $13.70 -26.76%
July, 2029 $13.00 $11.64 $16.01 -27.07%
August, 2029 $15.30 $11.06 $16.76 -14.20%
September, 2029 $16.66 $14.67 $17.68 -6.54%
October, 2029 $16.23 $14.55 $17.70 -8.99%
November, 2029 $12.52 $12.23 $16.27 -29.76%
December, 2029 $10.92 $9.02 $18.07 -38.75%

Myriad Genetics Inc Stock (MYGN) Price Forecast for 2030

Myriad Genetics Inc Stock (MYGN) is expected to reach an average price of $15.72 in 2030, with a high forecast of $31.13 and a low forecast of $0.3058. This signifies an -11.84% decrease from the last price of $17.83.
Month Average Low High Change from today's price
January, 2030 $7.0187 $6.0332 $10.55 -60.64%
February, 2030 $8.8297 $5.1142 $11.40 -50.48%
March, 2030 $30.17 $8.3975 $31.13 +69.21%
April, 2030 $6.6817 $5.2517 $30.27 -62.53%
May, 2030 $11.98 $6.3895 $14.49 -32.84%
June, 2030 $15.64 $10.90 $16.59 -12.27%
July, 2030 $8.6702 $3.5147 $18.43 -51.37%
August, 2030 $10.86 $7.9633 $11.11 -39.08%
September, 2030 $11.78 $8.1231 $12.25 -33.95%
October, 2030 $3.1209 $3.0429 $13.78 -82.50%
November, 2030 $3.7881 $0.3058 $4.0187 -78.75%
December, 2030 $4.0371 $2.6949 $2.5904 -77.36%
$218.80
price down icon 0.73%
diagnostics_research LH
$227.17
price up icon 0.03%
diagnostics_research WAT
$387.34
price up icon 0.03%
$153.49
price up icon 2.49%
diagnostics_research MTD
$1,364.02
price up icon 1.63%
$414.52
price down icon 0.66%
Cap:     |  Volume (24h):